Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Felix Sahm

Showing results (91-100 of 450) with videos related to

Pageof 45
Sort By:
Neuro-Oncology|November 12, 2024
The prognostic impact of CDKN2A/B hemizygous deletions in IDH-mutant gliomaFranziska M Ippen, Thomas Hielscher, Dennis Friedel, et al.
Acta Neuropathologica|June 7, 2024
Clinically unfavorable transcriptome subtypes of non-WNT/non-SHH medulloblastomas are associated with a predominance in proliferating and progenitor-like cell subpopulationsKonstantin Okonechnikov, Daniel Schrimpf, Jan Koster, et al.
Histopathology|August 21, 2015
Differential nuclear ATRX expression in sarcomasChristian Koelsche, Marcus Renner, Pascal Johann, et al.
Acta Neuropathologica Communications|January 12, 2023
Comparison of transcriptome profiles between medulloblastoma primary and recurrent tumors uncovers novel variance effects in relapsesKonstantin Okonechnikov, Aniello Federico, Daniel Schrimpf, et al.
Cancer Research|April 4, 2013
The endogenous tryptophan metabolite and NAD+ precursor quinolinic acid confers resistance of gliomas to oxidative stressFelix Sahm, Iris Oezen, Christiane A Opitz, et al.
Clinical Neuroradiology|March 27, 2026
From Anatomy to Outcome: Linking Glioma Location Patterns to Survival Using Non-Negative Matrix FactorizationMarianne Schell, Joel Kohler, Martha Folty-Dumitru, et al.
Acta Neuropathologica|September 27, 2022
Genetic and epigenetic profiling identifies two distinct classes of spinal meningiomasFranz L Ricklefs, Krystian D Fita, Malte Mohme, et al.
Brain Pathology (Zurich, Switzerland)|February 25, 2022
Prognostic impact of genetic alterations and methylation classes in meningiomaAnna S Berghoff, Thomas Hielscher, Gerda Ricken, et al.
Neuro-Oncology|October 29, 2025
Integrated transcriptomic landscape of medulloblastoma and ependymoma reveals novel tumor subtype-specific biologySonali Arora, Nicholas Nuechterlein, Matt Jensen, et al.
Neurosurgical Review|September 6, 2024
Decoding pediatric spinal tumors: a single-center retrospective case series on etiology, presentation, therapeutic strategies, and outcomesPavlina Lenga, Daniel Kühlwein, Martin Grutza, et al.
Pageof 45

Showing results (91-100 of 450) with videos related to

Sort By:
Pageof 45
Neuro-Oncology|November 12, 2024
The prognostic impact of CDKN2A/B hemizygous deletions in IDH-mutant gliomaFranziska M Ippen, Thomas Hielscher, Dennis Friedel, et al.
Acta Neuropathologica|June 7, 2024
Clinically unfavorable transcriptome subtypes of non-WNT/non-SHH medulloblastomas are associated with a predominance in proliferating and progenitor-like cell subpopulationsKonstantin Okonechnikov, Daniel Schrimpf, Jan Koster, et al.
Histopathology|August 21, 2015
Differential nuclear ATRX expression in sarcomasChristian Koelsche, Marcus Renner, Pascal Johann, et al.
Acta Neuropathologica Communications|January 12, 2023
Comparison of transcriptome profiles between medulloblastoma primary and recurrent tumors uncovers novel variance effects in relapsesKonstantin Okonechnikov, Aniello Federico, Daniel Schrimpf, et al.
Cancer Research|April 4, 2013
The endogenous tryptophan metabolite and NAD+ precursor quinolinic acid confers resistance of gliomas to oxidative stressFelix Sahm, Iris Oezen, Christiane A Opitz, et al.
Clinical Neuroradiology|March 27, 2026
From Anatomy to Outcome: Linking Glioma Location Patterns to Survival Using Non-Negative Matrix FactorizationMarianne Schell, Joel Kohler, Martha Folty-Dumitru, et al.
Acta Neuropathologica|September 27, 2022
Genetic and epigenetic profiling identifies two distinct classes of spinal meningiomasFranz L Ricklefs, Krystian D Fita, Malte Mohme, et al.
Brain Pathology (Zurich, Switzerland)|February 25, 2022
Prognostic impact of genetic alterations and methylation classes in meningiomaAnna S Berghoff, Thomas Hielscher, Gerda Ricken, et al.
Neuro-Oncology|October 29, 2025
Integrated transcriptomic landscape of medulloblastoma and ependymoma reveals novel tumor subtype-specific biologySonali Arora, Nicholas Nuechterlein, Matt Jensen, et al.
Neurosurgical Review|September 6, 2024
Decoding pediatric spinal tumors: a single-center retrospective case series on etiology, presentation, therapeutic strategies, and outcomesPavlina Lenga, Daniel Kühlwein, Martin Grutza, et al.
Pageof 45